Elisabetta Aldieri

Elisabetta Aldieri is an Associate Professor in the Department of Oncology at the University of Turin, specializing in molecular mechanisms underlying malignant pleural mesothelioma (MPM) and asbestos-related pathologies. Her research focuses on oxidative stress, epithelial-mesenchymal transition (EMT), and TGF-β signaling in cancer development and metastasis. She is actively involved in academic governance, serving on the Department Council and Teaching Commission.

Her teaching responsibilities include courses in Biochemistry for Nursing and Medical degree programs, emphasizing structural biochemistry and metabolic pathways. Research priorities include identifying redox-sensitive biomarkers, understanding asbestos carcinogenesis, and exploring therapeutic targets in MPM. Notable contributions involve studying nanomaterial toxicity and environmental asbestos risk assessment. Her work bridges basic science with clinical applications, particularly in cancer biology and environmental health.

Recent publications highlight advancements in platinum-based therapies for mesothelioma, TGF-β-driven cancer progression, and vitamin D's role in suppressing EMT. She collaborates on interdisciplinary projects addressing asbestos exposure, nanotoxicology, and molecular oncology.